These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Gliomatosis Cerebri Among Children and Adolescents: An Individual-Patient Data Meta-analysis of 182 Patients. Georgakis MK, Tsivgoulis G, Pourtsidis A, Petridou ET. J Child Neurol; 2019 Jun; 34(7):394-401. PubMed ID: 30887873 [Abstract] [Full Text] [Related]
7. Gliomatosis cerebri: 20 years of experience at the Children's Hospital of Philadelphia. Armstrong GT, Phillips PC, Rorke-Adams LB, Judkins AR, Localio AR, Fisher MJ. Cancer; 2006 Oct 01; 107(7):1597-606. PubMed ID: 16955507 [Abstract] [Full Text] [Related]
8. Predictive factors for overall survival in surgical cases of gliomatosis cerebri from the National Cancer Database. Khalafallah AM, Kopparapu S, Mukherjee D. J Clin Neurosci; 2020 Nov 01; 81():186-191. PubMed ID: 33222914 [Abstract] [Full Text] [Related]
10. Clinical, neuroimaging and histopathological features of gliomatosis cerebri: a systematic review based on synthesis of published individual patient data. Georgakis MK, Tsivgoulis G, Spinos D, Dimitriou NG, Kyritsis AP, Herrlinger U, Petridou ET. J Neurooncol; 2018 Nov 01; 140(2):467-475. PubMed ID: 30117023 [Abstract] [Full Text] [Related]
11. Relationship between treatment effects on progression-free survival and overall survival in multiple myeloma: a systematic review and meta-analysis of published clinical trial data. Cartier S, Zhang B, Rosen VM, Zarotsky V, Bartlett JB, Mukhopadhyay P, Wagner S, Davis C. Oncol Res Treat; 2015 Nov 01; 38(3):88-94. PubMed ID: 25792079 [Abstract] [Full Text] [Related]
12. Gliomatosis cerebri (GC) or GC-like? A picture to be reconsidered in neuro-oncology based on large retrospective analysis of GC series. Anghileri E, Schettino C, Pollo B, Farinotti M, Silvani A, Paterra R, Patanè M, DiMeco F, Bruzzone MG, Eoli M, Cuccarini V. Neurol Sci; 2020 Aug 01; 41(8):2111-2120. PubMed ID: 32114667 [Abstract] [Full Text] [Related]
13. Gliomatosis cerebri having a poor performance status without recurrence after radiotherapy: a single institutional experience. Jung TY, Yoon MS, Kim YH, Jung S, Kim IY, Jang WY, Moon KS, Lee KH, Kim SK. Clin Neurol Neurosurg; 2015 Mar 01; 130():1-5. PubMed ID: 25569296 [Abstract] [Full Text] [Related]
14. Gliomatosis cerebri: a review of 22 cases. Vates GE, Chang S, Lamborn KR, Prados M, Berger MS. Neurosurgery; 2003 Aug 01; 53(2):261-71; discussion 271. PubMed ID: 12925240 [Abstract] [Full Text] [Related]
15. Association between small heat shock protein B11 and the prognostic value of MGMT promoter methylation in patients with high-grade glioma. Cheng W, Li M, Jiang Y, Zhang C, Cai J, Wang K, Wu A. J Neurosurg; 2016 Jul 01; 125(1):7-16. PubMed ID: 26544773 [Abstract] [Full Text] [Related]
18. Surrogacy of progression free survival for overall survival in metastatic breast cancer studies: Meta-analyses of published studies. Kundu MG, Acharyya S. Contemp Clin Trials; 2017 Feb 01; 53():20-28. PubMed ID: 27940185 [Abstract] [Full Text] [Related]
20. Gliomatosis Cerebri Growth Pattern: Association of Differential First-Line Treatment with Overall Survival in WHO Grade II and III Gliomas. Divé I, Steidl E, Wagner M, Filipski K, Burger MC, Franz K, Harter PN, Bähr O, Fokas E, Herrlinger U, Steinbach JP. Oncology; 2021 Nov 01; 99(4):215-224. PubMed ID: 33472203 [Abstract] [Full Text] [Related] Page: [Next] [New Search]